MALDI-TOF Mass Defect Evaluation for Peptide Data Quality
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current mass spectrometry techniques for analyzing peptides from biological samples face challenges in accurately assessing data quality due to systematic errors and the complexity of the data, lacking broad and easily applicable standards for evaluating the comparability of measurement quality.
Innovation Solution
A procedure involving the provision of expected mass defects, determination of measured mass defects, and comparison with expected values to assess data quality, using a computer-aided visualization of mass defects and signal correction to evaluate and improve the accuracy of mass spectrometric data.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional mass spectrometry methods are used to analyze peptides from biological samples, then measurement data is obtained, but systematic errors and data complexity prevent objective assessment of data quality and accuracy
Solution Approach 1:
The patent introduces an intermediary evaluation system that uses reference mass defect patterns as a mediator between the complex mass spectrometry data and the quality assessment. This intermediary layer translates complex spectral data into comparable quality metrics through systematic comparison with reference patterns, enabling objective quality assessment without directly confronting the full complexity of the raw data
Solution Approach 2:
The patent transforms the complex multidimensional mass spectrometry data into a simplified parameter space by focusing on mass defect patterns. By changing the evaluation parameters from raw spectral intensity and m/z values to mass defect deviations from reference patterns, the system enables objective quality comparison while reducing the impact of data complexity
2Reliability
If conventional mass spectrometry methods are used to analyze peptides from biological samples, then measurement data is obtained, but lack of widely accepted metrics prevents comparison of data quality between measurements
Solution Approach 1:
The patent creates a universal evaluation framework based on mass defect patterns that can be applied across different mass spectrometry measurements and instruments. This universal approach uses standardized reference patterns and comparison metrics that work consistently across various experimental conditions, enabling data quality comparison without requiring complex, measurement-specific evaluation procedures
Solution Approach 2:
The patent uses reference mass defect patterns as idealized copies of expected peptide signal characteristics. By comparing actual measurements against these reference copies, the system establishes a standardized basis for quality assessment that is both simple to implement and universally applicable across different measurements and laboratories
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables objective evaluation of data quality, corrects signal errors, and ensures the reliability of mass spectrometric measurements by comparing measured mass defects with expected patterns, thereby improving the accuracy and consistency of peptide analysis.
Implementation Method 1
a biological tissue sample is coated with a matrix solution after suitable sample preparation and then bombarded with a laser in a vacuum. This dissolves biological macromolecules from the tissue and ionizes them
Implementation Method 2
This dissolves biological macromolecules from the tissue and ionizes them, typically with a singly positive charge
Implementation Method 3
The ions are then accelerated in an electric field and registered by a detector. The m/z value, i.e. the relationship between the mass and charge of the molecule, can be determined from the time of flight
Implementation Method 4
The ions are then accelerated in an electric field and registered by a detector. The m/z value, i.e. the relationship between the mass and charge of the molecule, can be determined from the time of flight
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to a method for evaluating data from mass spectrometry for the analysis of peptides from biological samples, in particular from MALDI-TOF mass spectrometry, having the following steps: a) providing expected mass defects; b) determining measured mass defects, namely the mass defects resulting from the data from the mass spectrometry; c) comparing the measured mass defects with the expected mass defects.